Unlocking Treg Functional Pathways to Drive Therapeutic Innovation

• Investigating the key drivers and surface molecules required for Treg functionality
• Highlighting necessity for the cGAS/STING/type I IFN axis for induction of tolerance (via Treg induction) by antigen-loaded PLGA nanoparticles
• Exploring novel therapies that have leveraged these mechanisms of action to regulate the immune response

Speakers:

Stephen Miller

Professor of Microbiology-Immunology

Northwestern University